Results 1 to 10 of about 19,181 (266)

Reversible hypopigmentation with pazopanib

open access: yesIndian Journal of Medical and Paediatric Oncology, 2018
Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible hypopigmentation with Pazopanib in a patient treated for spindle cell sarcoma.
B J Srinivasa   +3 more
doaj   +2 more sources

Steroid-induced perilymphatic hypopigmentation: Response to tacrolimus

open access: diamondPigment International, 2018
Intralesional steroids are commonly used in dermatological practice. This route of administration has the advantage of minimal side effects. However, other adverse reactions namely local atrophy, ulceration, infections, etc. have been noted. One peculiar
Sneha Ghunawat, Rashmi Sarkar
doaj   +2 more sources

The first report of krt5 mutation underlying acantholytic dowling-degos disease with mottled hypopigmentation in an Indian family

open access: diamondIndian Journal of Dermatology, 2014
Galli Galli disease (GGD) is the name given to a rare form of acantholytic Dowling-Degos disease. (DDD), the latter itself being a rare condition. We believe we are describing for the first time in Indian dermatologic literature a case of GGD in a family
Shyam Verma   +5 more
doaj   +2 more sources

Hypopigmentation of the Skin and Hair Associated with Dasatinib Therapy

open access: diamondTurkish Journal of Hematology, 2023
Vishnu Sharma, Vansh Bagrodia
doaj   +2 more sources

Postinflammatory hypopigmentation [PDF]

open access: yesClinical and Experimental Dermatology, 2011
Postinflammatory hypopigmentation is a common cause of acquired hypopigmentary disorders. It can be a result of cutaneous inflammation, injury or dermatological treatment. There are also many specific conditions that present with hypopigmentation other than postinflammatory hypopigmentation.
V. Vachiramon, K. Thadanipon
  +5 more sources

Correlation of Dermatology Life Quality Index and Vitiligo Extent Tensity Index: A Cross-sectional Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: Vitiligo is a chronic depigmentary disorder having an autoimmune aetiology. Vitiligo has a severe impact on the quality of life of the individual in our country. Considering the changing socio-economic trend and the arrival of new medicines
Naveen Netaji Rao   +2 more
doaj   +1 more source

Pigmentary abnormality without significant drusen as a risk factor for late age-related macular degeneration

open access: yesScientific Reports, 2022
We investigated the incidence and risk factors of late age-related macular degeneration (AMD) in the fellow eye (FE) without significant drusen of patients with unilateral exudative macular neovascularization (MNV).
Junwon Lee   +6 more
doaj   +1 more source

Vulvar lesion mimicking vitiligo: A case report

open access: yesCase Reports in Women's Health, 2020
Background: Post-inflammatory hypopigmentation (PIH) is an acquired partial or total loss of pigment that occurs as a result of cutaneous inflammation. Clinically, post-inflammatory hypopigmentation is recognized by a discoloration of the skin; however ...
Paula Gutierrez   +4 more
doaj   +1 more source

Pigmentary changes associated with endocrine and metabolic disorders

open access: yesPigment International, 2021
Pigmentary changes in skin can act as an interface to diagnose and monitor various systemic diseases. Endocrine and metabolic disorders can directly or indirectly affect melanin synthesis pathway, thus affecting melanogenesis and skin color.
Pooja Arora, Sinu Rose Mathachan
doaj   +1 more source

Home - About - Disclaimer - Privacy